NCT02777541

Brief Summary

There aren't sufficient randomized prospective controlled trials in pediatric population comparing the safety and tolerance of early feeding after PEG placement (3-4 hours). Most patients are fasted for at least 12 hours following percutaneous endoscopic gastrostomy. In order to decrease the period of fasting, inadequate nutritional support, and hospitalization time, the investigators decided to design this study. The additional goal is to establish an optimum standard procedure in the group of pediatric patients qualified for PEG insertion procedure in Poland.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 16, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 19, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

May 20, 2016

Status Verified

May 1, 2016

Enrollment Period

2 years

First QC Date

May 16, 2016

Last Update Submit

May 18, 2016

Conditions

Keywords

early enteral nutritionchildrenpercutaneous endoscopic gastrostomy

Outcome Measures

Primary Outcomes (1)

  • Number of patients who will achieve full feed (total fluid and caloric requirements) within 48 hours since the first feeding bolus.

    48 hours

Secondary Outcomes (4)

  • Number of early complications (to 6 days after PEG placement)

    to 6 days after PEG placement

  • Number of late complications ( 7 days - 12 months after PEG placement)

    7 days- 12 months after PEG placement

  • Number of hospitalization days after PEG placement

    up to 30 days

  • Gastric residuals (ml) - sum up to 48 hours since the first feeding bolus

    48 hours

Other Outcomes (7)

  • Improvement in nutritional status

    12 months

  • Influence of vitamin and trace element deficiency on complications rate.

    12 months

  • Influence of ghrelin, leptin and adiponectin level on nutritional status

    12 months

  • +4 more other outcomes

Study Arms (2)

Early enteral nutrition

OTHER

3 hours after PEG implantation

Dietary Supplement: Resumption of feeding 3 hours after PEG placement

Late enteral nutrition

OTHER

8 hours after PEG implantation

Dietary Supplement: Resumption of feeding 8 hours after PEG placement

Interventions

The first feeding will be with polymeric diet (1 kcal/ml). First feeding portion will have the volume equal to 1/3 of full recommended portion, volume of second feeding will be equal to 2/3 of full recommended portion and third portion will be equal to full recommended portion. Each portion will introduced thru the enteral feeding pump (Flocare Infinity, Nutricia), for 30 minutes, three-hour break between feeds. Infusion of 5% glucose solution with electrolytes will be given through intravenous line to cover maintenance fluid requirement in all subjects.

Early enteral nutrition

The first feeding will be with polymeric diet (1 kcal/ml). First feeding portion will have the volume equal to 1/3 of full recommended portion, volume of second feeding will be equal to 2/3 of full recommended portion and third portion will be equal to full recommended portion. Each portion will introduced thru the enteral feeding pump (Flocare Infinity, Nutricia), for 30 minutes, three-hour break between feeds. Infusion of 5% glucose solution with electrolytes will be given through intravenous line to cover maintenance fluid requirement in all subjects.

Late enteral nutrition

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Subjects between 1 month-old and 18 years-old
  • Medical indications for percutaneous endoscopic gastrostomy (PEG) placement.
  • Informed consent to participate in the study signed and dated by the subject's parent/legal guardian and the also by patient over the age of 16 years.

You may not qualify if:

  • Serious, uncorrectable coagulation disorders.
  • Inability to perform upper gastrointestinal (UGI) series endoscopy (laryngeal or oesophageal stricture)
  • Need for concomitant fundoplication.
  • Lack of technical ability to perform PEG placement procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastroenterology, Hepatology and Feeding Disorders

Warsaw, 04-730, Poland

RECRUITING

Related Publications (2)

  • Wiernicka A, Matuszczyk M, Szlagatys-Sidorkiewicz A, Landowski P, Toporowska-Kowalska E, Gebora-Kowalska B, Popinska K, Sibilska M, Grzybowska-Chlebowczyk U, Wiecek S, Hapyn E, Blimke-Koziel K, Kierkus J. Tolerability and safety of early enteral nutrition in children after percutaneous endoscopic gastrostomy placement: A multicentre randomised controlled trial. Clin Nutr. 2019 Aug;38(4):1544-1548. doi: 10.1016/j.clnu.2018.08.018. Epub 2018 Aug 28.

  • Wiernicka A, Matuszczyk M, Szlagatys-Sidorkiewicz A, Toporowska-Kowalska E, Popinska K, Chlebowczyk-Grzybowska U, Hapyn E, Kierkus J. The protocol for a randomised-controlled trial of the evaluation of the tolerance and safety of early enteral nutrition in children after percutaneous endoscopic gastrostomy placement. (protocol version 09.01.2015). BMC Pediatr. 2016 Oct 7;16(1):163. doi: 10.1186/s12887-016-0705-8.

Central Study Contacts

Jaroslaw Kierkus

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

May 16, 2016

First Posted

May 19, 2016

Study Start

January 1, 2015

Primary Completion

January 1, 2017

Study Completion

December 1, 2017

Last Updated

May 20, 2016

Record last verified: 2016-05

Locations